✦ LIBER ✦

367 A first-in-human Phase 1 study of anti-CD105 antibody therapy with TRC105 in patients with advanced solid tumors

✍ Scribed by L. Rosen; M.S. Gordon; H.I. Hurwitz; M.K. Wong; J. Goldman; B.J. Adams; D. Alvarez; B.K. Seon; C.P. Theuer; B.R. Leigh

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

400 POSTER Early evidence of tolerabilit

✍ L.S. Rosen; M.S. Gordon; H.I. Hurwitz; D.S. Mendelson; D. Kleinzweig; B.J. Adams 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 58 KB

A phase I study of the human monoclonal

✍ Weekes, Colin D.; Beeram, Muralidhar; Tolcher, Anthony W.; Papadopoulos, Kyriako 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 387 KB

A phase I study of an agonist anti-CD27

✍ Howard Burris,Stephen Ansell,John Neumanitis… 📂 Article 📅 2013 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 65 KB

A phase I study of an agonist anti-CD27

✍ Stephen Ansell,Donald Northfelt,Ian Flinn… 📂 Article 📅 2013 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 65 KB

A phase 1 study of TRC102, an inhibitor

✍ Gordon, Michael S.; Rosen, Lee S.; Mendelson, David; Ramanathan, Ramesh K.; Gold 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 224 KB

A phase 1 study of gemcitabine combined

✍ David S. Hong, Jennifer Hsing Choe, Aung Naing, Jennifer J. Wheler, Gerald S. Fa 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 335 KB